<img src="https://secure.leadforensics.com/133892.png" alt="" style="display:none;">

Columbus and ABG Sundal Collier have the pleasure of inviting investors, analysts and the media to a Capital Market Day, Thursday, March 22, 2018 at ABG Sundal Collier, Copenhagen.

Columbus and ABG Sundal Collier have the pleasure of inviting investors, analysts and media to a Capital Market Day, Thursday, March 22, 2018 at ABG Sundal Collier, Copenhagen.

The day will provide a detailed presentation of the acquisition of iStone, announced 2 January 2018.

The presentation will include the strategic rationale for the acquisition, the Stronger Together integration plan and the short-term and long-term priorities.

Columbus will be represented by:
Ib Kunøe, Chairman of the Board
Thomas Honoré, CEO and President
Hans Henrik Thrane, Corporate CFO
Markus Jakobson, Managing Director, iStone Sweden

Agenda:
Registration and coffee
Welcome and introduction
Presentation of iStone
Strategic rationale for the acquisition
Stronger Together Integration plan
Short-term and long-term priorities
Wrap up and Questions

Sign up:
Nicole Dahl, Event Coordinator
T: +45 35 46 30 20
E: Nicole.Dahl@abgsc.dk

Time and place:
22 March 2018, at 14:00 – 16:00 CET
ABG Sundal Collier, Forbindelsesvej 12, 2100 København Ø

Discuss this post

Recommended posts

Minneapolis, Minn. (July 9, 2020): Columbus U.S. has announced a partnership with orthopedic medical device contract manufacturer Mach Medical. Using Microsoft technology, the Columbus U.S. team will help Mach Medical as they revolutionize the orthopedic supply chain by creating a manufacturing organization capable of building the highest quality joint replacement implants from a patient’s pre-operative surgical plan and supplying that product in time for surgery. Mach Medical’s proprietary high velocity, single-piece flow manufacturing approach is designed to reduce OEM implant inventory levels by 80%, trim per-part manufacturing costs by 30%, and cut new product time-to-market by 1-2 years.
Columbus continued the positive development from 2019 with revenue growth in the first two months of the year until COVID-19 hit the world community. Columbus is fully focused on serving customers digitally, adapting the business to the new situation and launching new digital sales and marketing initiatives to increase sales.
2019 was a good year for Columbus with 4% organic growth and EBITDA growth of 39%. The positive development continued in the first two months of the year, after which COVID-19 changed the conditions for 2020. Columbus is fully focused on serving customers and adapting the business to the changing situation.
With an organic growth of 5% in Q3 and EBITDA growth of 48% in Q3 YTD, Columbus delivers a satisfactory result for the first 9 months, thus maintaining the expectations for the year.
With an EBITDA growth of 7%, Columbus delivers a satisfactory first half of 2019, and maintains full year expectations.
right-arrow share search phone phone-filled menu filter envelope envelope-filled close checkmark caret-down arrow-up arrow-right arrow-left arrow-down